Salute e Benessere

Nebulizer Market to Reach $2.3 Billion by 2032, exhibiting a CAGR of 7.8% from…

Request Sample of the Report on Nebulizer Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/403 Request Sample of the Report on Nebulizer Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/403 Prime determinants of growth Increase in prevalence of asthma and rise in awareness among people regarding use of nebulizers in homecare settings are anticipated to boost the growth of the market. However, high cost of nebulizer is anticipated...
PR Newswire
15/11/2023

Mallinckrodt Completes Financial Restructuring and Irish Examinership…

Supported by an enhanced capital structure, Mallinckrodt will continue to focus on advancing its business across its portfolio and executing on recent and planned product launches. The Company has made meaningful recent progress to stabilize the business, including achieving year-over-year net sales growth for the second consecutive quarter and year-over-year adjusted EBITDA growth for the third quarter 2023. Supported by an enhanced capital structure,Mallinckrodtwill continue to focus on...
PR Newswire
15/11/2023

Neurofibromatosis Type 2 Market to Observe Impressive Growth by 2032, Evaluates…

Key Takeaways from the Neurofibromatosis Type 2 Market Report Key Takeaways from the Neurofibromatosis Type 2 Market Report Discover which therapies are expected to grab the major neurofibromatosis type 2 market share @Neurofibromatosis Type 2 Market Report Neurofibromatosis Type 2 Overview Neurofibromatosis type 2 (NF2) is a rare genetic disorder that affects the nervous system, primarily causing tumors to develop on the nerves. Unlike Neurofibromatosis Type 1, NF2 is less...
PR Newswire
14/11/2023

PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023

Conference call and webcast (English) on Wednesday, November 15, 2023 at 8:30am ET / 2:30pm CETAmbitious clinical development strategy progressing to create a global phage therapy leader in high-value indicationsEarly access program continues to gain momentum with the treatment of more than 90 patients suffering from severe and resistant infection prosthetic joint infections of the hip or knee (PJI) Cash and cash equivalents of €15.6 million ($16.5 million) as of September 30,...
Nasdaq GlobeNewswire
14/11/2023

MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference

NEWS RELEASE November 14, 2023, 4PM ET/ 22:00 CETMDxHealth to Participate in the 35 thAnnual Piper SandlerHealthcare ConferenceIRVINE, CA, and HERSTAL, BELGIUM– November 14, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in a fireside chat at the 35 thPiper Sandler Healthcare Conference on Wednesday, November 29,...
Nasdaq GlobeNewswire
14/11/2023

Regenerative Medicine and Stem Cell Therapies Fuel Cell Line Development Market…

The global cell line development market value is expected to rise from US$ 3,124.4 million in 2023 to US$ 4,674.8 millionby 2033. Over the forecast period, demand for cell line products is set to rise at a CAGR of 4.1%. The global cell line development market value is expected to rise from US$ 3,124.4 million in 2023 to US$ 4,674.8 millionby 2033. Over the forecast period, demand for cell line products is set to rise at aCAGRof4.1%. To get a preview of our comprehensive cell...
PR Newswire
14/11/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 45 - 2023

Statement of transactions in own shares from November 06 to November 10, 2023BNP PARIBAS Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume...
Nasdaq GlobeNewswire
14/11/2023

Digital Health Market Worth $549.7 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45458752 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=45458752 Browse in-depth TOC on "Digital Health Market" 231 - Tables 49 - Figures 301 - Pages Digital Health Market Scope: "Hardware segment is expected to grow at the highest rate during the forecast period" Based on offering, the digital...
PR Newswire
14/11/2023

Luxury E-Commerce Platforms Market to Record an Exponential CAGR by 2031 -…

Luxury E-Commerce Platforms Market Report Scope Luxury E-Commerce Platforms Market Report Scope Free PDF Sample Report Brochure: https://www.insightaceanalytic.com/request-sample/2130 Recent Developments: Luxury e-commerce is used to describe the online trade in expensive, usually designer, items. Luxury brands provide their clients with a VIP service, from individualized recommendations to posh packaging that impresses from the first click to the first unboxing...
PR Newswire
14/11/2023

Fungal Infections Drive Demand for Anti-fungal Therapies, Market to Reach…

To get a preview of our comprehensive antifungal therapies market research report before you purchase, click here to request a sample report. To get a preview of our comprehensive antifungal therapies market research report before you purchase,click here to request a sample report. The increasing fungal disease rate has forced the patient to take anti-fungal drugs, driving the market growth. For instance, onMay 20, 2020, according to Fungal Infections in Humans, around 1...
PR Newswire
14/11/2023

Pulsed Field Ablation Market to Record an Exponential CAGR by 2031 - Exclusive…

Pulsed Field Ablation Market Report Scope Pulsed Field Ablation Market Report Scope Free PDF Sample Report Brochure: https://www.insightaceanalytic.com/request-sample/2181 Recent Developments Pulsed Field Ablation (PFA) is a medical technology used to treat cardiac arrhythmias, particularly atrial fibrillation (AF). Market is a minimally invasive procedure that uses high-energy electrical fields to create localized lesions in the heart tissue, disrupting the abnormal...
PR Newswire
14/11/2023

Demand for Floral Nectar to Reach US$7.3 Billion by 2034, Driven by Natural…

NEWARK, Del., Nov. 14, 2023 /PRNewswire/ -- The floral nectar market will be valued at US$ 4,606.5 million in 2024. In 2023, the market registered a valuation of US$ 3,332.3 million. The market is expected to progress steadily over the forecast period from 2024 to 2034, with a CAGR of 4.8%. By 2034, the value of the market is forecast to jump to US$ 7,350.8 million. NEWARK, Del.,Nov. 14, 2023/PRNewswire/ -- The floral nectar market will be valued at US$ 4,606.5 millionin 2024...
PR Newswire
14/11/2023

Occupational Medicines Market to hit USD USD 22.5 billion by 2031, at a CAGR…

Companies are increasingly implementing wellness programs to enhance employee well-being and productivity. These programs aim to meet employees' healthcare needs on a proactive and reactive basis through occupational medicine. Employees and employers benefit from occupational medicine by reducing absences, improving productivity, and reducing long-term healthcare costs through early detection and prevention. Companies are increasingly implementing wellness programs to enhance employee...
PR Newswire
14/11/2023

EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023

Highlighting the new addition to its product lineup, EDAN introduced three gynecology products, showcasing its ongoing progress and reinforcing its status as a forefront technology leader in enhancing women's healthcare. Of noteworthy mention is the overseas debut of the Q andS Series handheld biofeedback and stimulation system, extending its current portfolio and adding valuable rehabilitation applications to its offerings, drawing significant interest from attendees. Highlighting the new...
PR Newswire
14/11/2023

Theranica Enters Into Agreement With Dr. Reddy's for Commercializing Nerivio® in…

This comes after Theranica announced in August this year that Nerivio®, a novel, drug-free REN (Remote Electrical Neuromodulation) wearable for migraine, has received an expanded CE mark approval under MDR European regulation as a dual-use (acute and/or prevention) migraine treatment for adults and adolescents. This comes after Theranica announced in August this year that Nerivio®, a novel, drug-free REN (Remote Electrical Neuromodulation) wearable for migraine, has received an expanded...
PR Newswire
14/11/2023

Essence SmartCare Completes Shipment of 140K Remote Care Devices to the…

This achievement underscores the resilience of Essence Group, as it continues to drive key business objectives. This shipment of Care@Home systems, that was all delivered in one day, is in accordance with a pre-determined supply schedule to meet the requirements of the Community of Madrid in providing advanced care technologies to allow seniors to live more independently. This achievement underscores the resilience of Essence Group, as it continues to drive key business objectives. This...
PR Newswire
14/11/2023

Lexogen Unveils LUTHOR High-Definition Single Cell 3' mRNA-Seq Kit…

The key to LUTHOR HD's exceptional sensitivity lies in its innovative THOR (T7 High-resolution Original RNA amplification) technology. By amplifying RNA directly from the original mRNA, rather than from cDNA as in conventional single-cell RNA-Seq protocols, LUTHOR HD overcomes the limitations of low-copy transcripts, making it an indispensable tool for gene expression profiling. The key to LUTHOR HD's exceptional sensitivity lies in its innovative THOR (T7 High-resolution Original RNA...
PR Newswire
14/11/2023

Dr. Alan Kivitz to Chair XBiotech's Natrunix Program in Rheumatoid Arthritis

(Phase II Multicenter Study is Proceeding Well with High Anticipation) XBiotech believes Natrunix will be a breakthrough therapy for rheumatological diseases. The company has now enrolled about 33% of the 210 patients it is recruiting for a Phase II, Double-Blind, Placebo-Controlled, Randomized study, examining Natrunix in combination with methotrexate for the treatment of Rheumatoid Arthritis. There are presently about 25 clinical trial sites across the United States that are participating...
Nasdaq GlobeNewswire
14/11/2023

Global Oncology Drugs Market Size Projected to Reach $484 Billion by 2030

Fortune business Insights added that the: "Increasing prevalence of cancer (will) augment the oncology drugs market growth. The rate of cancer incidence is increasing globally. Various factors responsible for this growth are urbanization, changing diet patterns, tobacco smoking, and extended post-reproductive lifespan. According to the GLOBOCAN 2022, cancer is a growing burden. Around 19.3 million new cancer cases occurred in 2022 worldwide. Furthermore, the cancer burden is projected to…
PR Newswire
14/11/2023

MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and…

MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update Announced positive full 24-week data from the global Phase 2 MIRA clinical trial, establishing the Nanobody ®sonelokimab as a highly promising and differentiated therapeutic solution for hidradenitis suppurativa Presented positive 12-week data from the global Phase 2 MIRA clinical trial for sonelokimab in hidradenitis suppurativa at a late-breaking session during the European...
Nasdaq GlobeNewswire
14/11/2023

Wyeth Becomes the First Multinational Company to Launch an HMO Growing-Up Infant…

The two HMOs in the novel illuma have been shown in clinical trials to help regulate gut microbiota, minimize the risk of bronchitis and respiratory infections, and reduce the need for antibiotics and fever reducers.[1] Additionally, 35 vital nutrients are added to the illuma HMO Growing-up Formula. These nutrients assist eye development, boost brain development, and address a host of other nutritional requirements for children's growth in addition to boosting immunity.[2] The two HMOs in the...
PR Newswire
14/11/2023

Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki…

JamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada. Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and JAMP Pharma Group (“JAMP Pharma”), a Canadian owned pharmaceutical organization headquartered in the Greater Montreal area, announced today that Health Canada has granted JAMP Pharma marketing authorization for AVT04, a...
Nasdaq GlobeNewswire
14/11/2023

Immatics Announces Third Quarter 2023 Financial Results and Business Update

ACTengine® IMA203 GEN1 TCR-T targeting PRAME showed 50% (6/12) confirmed ORR in melanoma patients with median duration of response (mDOR) not reached at median follow-up of 14.4 months including responses ongoing at >15 months after infusion; IMA203 GEN1 continues to be well tolerated; company is targeting registration-enabling Phase 2 trial in melanoma to commence in 2024; update on the clinical development plan in 1Q 2024First clinical data on ACTengine® IMA203CD8 GEN2 TCR-T targeting...
Nasdaq GlobeNewswire
14/11/2023

Igniting a New Era in Global Health: Hevolution Foundation Announces Its…

Additionally, over 100 distinguished speakers from more than 10 countries, including experts from across Saudi Arabia, Egypt, Germany, the Netherlands, Singapore, Spain, Switzerland, the UK, and the US, will discuss one of the most urgent issues of our time – healthy human healthspan. Additionally, over 100 distinguished speakers from more than 10 countries, including experts from acrossSaudi Arabia,Egypt,Germany,the Netherlands,Singapore,Spain,Switzerland, the UK, and the...
PR Newswire
14/11/2023
Altri  Comunicati